← FDA Drug Approvals (Drugs@FDA)

TOFACITINIB CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2021-06-01

Drug application

FDA Application #
ANDA212943
Application type
Abbreviated New Drug Application (Generic)
Brand name
TOFACITINIB CITRATE
Generic name
Tofacitinib Citrate
Active ingredients
TOFACITINIB CITRATE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
AJANTA PHARMA LTD
First approval
2021-06-01

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown